FibroGen, Inc (FGEN) Social Stream



FibroGen, Inc (FGEN): $12.18

-0.11 (-0.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FGEN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

FIBROGEN INC (FGEN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering FIBROGEN INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 9 $30 $14 $24.333 $11.98 103.11%
2021-12-22 9 $29 $14 $21.166 $11.98 76.68%
2022-01-06 9 $29 $14 $21 $11.98 75.29%
2022-01-13 8 $29 $14 $19.6 $11.98 63.61%
2022-03-01 7 $29 $14 $19.6 $11.98 63.61%
2022-03-02 7 $29 $13 $19.2 $11.98 60.27%
2022-05-10 6 $25 $13 $16.75 $11.98 39.82%
2022-05-11 6 $25 $9 $14.5 $11.98 21.04%
2022-05-24 5 $25 $8 $13.2 $11.98 10.18%
2022-08-08 7 $25 $8 $13.2 $11.98 10.18%
2022-09-10 7 $25 $8 $14.4 $11.98 20.2%

The Trend in the Analyst Price Target


FGEN's average price target has moved down $44.85 over the prior 28 months.

Over the past 44 weeks, FGEN's average upside potential has been 41.16%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-11 9 29 14 21.166 12.22 73.21%
2022-01-06 8 29 14 20.400 13.93 46.45%
2022-01-13 8 29 14 19.600 14.00 40%
2022-03-02 6 25 13 16.750 13.39 25.09%
2022-08-13 7 25 8 14.400 14.49 -0.62%

FGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.29 0 0 6 1 1 7

The Trend in the Broker Recommendations


Over the past 52 weeks, FGEN's average broker recommendation rating worsened by 0.49.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, FIBROGEN INC's variance in analysts' estimates is lower than -1069.09% of them.
  • To contextualize these metrics, consider that out of all US stocks, FIBROGEN INC's average analyst price target is greater than 295.87% of them.
  • In terms of how FIBROGEN INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 292.81% of that group.
  • In terms of how FIBROGEN INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 840.2% of that group.

Stocks similar to FIBROGEN INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EVO, ESPR, and ERAS.

What is the outlook for FGEN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6438 seconds.